TipRanks
Go Ultimate55% OFF

Ascletis Pharma, Inc. (1672) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

1672 Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to Ascletis Pharma, Inc. in the past 3 months

1672 Stock 12 Month Forecast

HKD 14.20▲(189.69% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Ascletis Pharma, Inc. in the last 3 months. The average price target is HKD 14.20 with a high forecast of HKD 14.53 and a low forecast of HKD 13.86. The average price target represents a 189.69% change from the last price of HKD 4.90.
Highest Price TargetHKD 14.53Average Price TargetHKD 14.20Lowest Price TargetHKD 13.86

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HK:1672
Price TargetFollowArticle
Orient Securities Analyst forecast on HK:1672Unknown AnalystNot RankedOrient SecuritiesHKD 13.83→HKD 14.53buy196.53%UpsideReiterated09/05/26
Goldman Sachs Analyst forecast on HK:1672Linhai Percy Zhao, Ph.D.Not RankedGoldman SachsHKD 15.71→HKD 13.86hold182.86%UpsideReiterated09/02/26
CitiHKD 32buy553.06%UpsideReiterated02/03/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ascletis Pharma, Inc.

3 Months
xAi Health Care HK
xAi Health Care HKTipRanks - xAI
Success Rate1/3 ratings generated profit
33%
Average Return
+0.70%

Copying xAi Health Care HK's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +0.70% per trade.

1 Year
xAi Health Care HK
xAi Health Care HKTipRanks - xAI
Success Rate1/3 ratings generated profit
33%
Average Return
+0.70%

Copying xAi Health Care HK's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +0.70% per trade.

2 Years
xAi Health Care HK
xAi Health Care HKTipRanks - xAI
Success Rate1/3 ratings generated profit
33%
Average Return
+0.70%

Copying xAi Health Care HK's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +0.70% per trade.

1672 Analyst Recommendation Trends

01234Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 1672
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy12321
Hold00111
Sell00000
Strong Sell00000
total12432

In the current month, 1672 has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 1672 average Analyst price target in the past 3 months is 14.20.

1672 Financial Forecast

HKD -2HKD -1.5HKD -1HKD -0.5HKD 0Q2 2025Q2 2026Q4 2026
HighHKD -0.49
ConsensusHKD -0.49
LowHKD -0.49

1672 Earnings Forecast

Next quarter’s earnings estimate for 1672 is -HKD 0.49 with a range of -HKD 0.49 to -HKD 0.49. The previous quarter’s EPS was -HKD 0.36. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

HKD -1HKD 347,953.3HKD 695,907.5HKD 1MHKD 1.4MQ2 2025Q2 2026Q4 2026
HighHKD 0.00
ConsensusHKD 0.00
LowHKD 0.00

1672 Sales Forecast

Next quarter’s sales forecast for 1672 is HKD 0 with a range of HKD 0 to HKD 0. The previous quarter’s sales results were HKD 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

1672 Stock Forecast FAQ

What is HK:1672’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascletis Pharma, Inc.’s 12-month average price target is HK$14.20.
What is HK:1672’s upside potential, based on the analysts’ average price target?
Ascletis Pharma, Inc. has 189.69% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ascletis Pharma, Inc. a Buy, Sell or Hold?
Ascletis Pharma, Inc. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Ascletis Pharma, Inc.’s share price target?
The average share price target for Ascletis Pharma, Inc. is HK$14.20. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$14.53, and the lowest forecast is HK$13.86. The average share price target represents a 189.69% increase from the current price of HK$4.9.
What do analysts say about Ascletis Pharma, Inc.?
Ascletis Pharma, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Ascletis Pharma, Inc.?
To buy shares of HK:1672, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.